Cargando…
Delivering Therapeutics to Glioblastoma: Overcoming Biological Constraints
Glioblastoma multiforme is the most lethal intrinsic brain tumor. Even with the existing treatment regimen of surgery, radiation, and chemotherapy, the median survival time is only 15–23 months. The invasive nature of this tumor makes its complete removal very difficult, leading to a high recurrence...
Autores principales: | Mathew, Elza N., Berry, Bethany C., Yang, Hong Wei, Carroll, Rona S., Johnson, Mark D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835860/ https://www.ncbi.nlm.nih.gov/pubmed/35163633 http://dx.doi.org/10.3390/ijms23031711 |
Ejemplares similares
-
Heterozygous FOXJ1 Mutations Cause Incomplete Ependymal Cell Differentiation and Communicating Hydrocephalus
por: Hou, Connie C., et al.
Publicado: (2023) -
Nestmate recognition in social insects: overcoming physiological constraints with collective decision making
por: Johnson, Brian R., et al.
Publicado: (2010) -
Therapeutic Strategies for Overcoming Immunotherapy Resistance Mediated by Immunosuppressive Factors of the Glioblastoma Microenvironment
por: Miyazaki, Tsubasa, et al.
Publicado: (2020) -
Targeting Glioblastoma Stem Cells to Overcome Chemoresistance: An Overview of Current Therapeutic Strategies
por: Kang, Hyunkoo, et al.
Publicado: (2022) -
MicroRNA-29a activates a multi-component growth and invasion program in glioblastoma
por: Zhao, Yun, et al.
Publicado: (2019)